Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 10, 2020 08:30 ET | Source: Fluidigm Corporation

Fluidigm Introduces AccuLift Laser Capture Microdissection System to Advance Translational and Clinical Pathology Research

SOUTH SAN FRANCISCO, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
March 10, 2020 02:00 ET | Source: INNATE PHARMA

Premier patient traité dans l’essai de Phase I évaluant IPH5201 chez des patients atteints de tumeurs solides avancées

Démarrage du premier essai clinique avec IPH5201, un anticorps monoclonal anti-CD39, première molécule de la collaboration étendue entre Innate et AstraZeneca à avancer au stade clinique Innate...
March 10, 2020 02:00 ET | Source: INNATE PHARMA

First patient dosed in IPH5201 Phase I clinical trial in advanced solid tumors

Anti-CD39 monoclonal antibody, IPH5201, advances to first-in-human clinical trial; first molecule from Innate/AstraZeneca expanded collaboration progressing to the clinic Innate Pharma SA (Euronext...
March 02, 2020 05:30 ET | Source: Immunicum AB

Immunicum AB (publ) meddelar att bolagets finanschef, Michaela Gertz, lämnar sin tjänst till sommaren 2020

Pressmeddelande 2 mars 2020 Immunicum AB (publ) meddelar att bolagets finanschef, Michaela Gertz, lämnar sin tjänst till sommaren 2020 Immunicum AB (publ) meddelar att bolagets finanschef...
March 02, 2020 05:30 ET | Source: Immunicum AB

Immunicum AB (publ) Announces that its CFO, Michaela Gertz, Will Leave the Company this Summer

Press Release 2 March 2020 Immunicum AB (publ) Announces that its CFO, Michaela Gertz, Will Leave the Company this Summer Immunicum AB (publ) announces that the company's CFO, Michaela Gertz,...
February 27, 2020 07:30 ET | Source: Adaptimmune Therapeutics plc

Adaptimmune Reports Fourth Quarter / Full Year 2019 Financial Results and Business Update

- Compelling data in synovial sarcoma in the Phase 1 trial, and continued momentum in the Phase 2 SPEARHEAD-1 trial with goal to launch ADP‑A2M4 for sarcoma in 2022 - - Encouraging...
February 18, 2020 02:00 ET | Source: Immunicum AB

Immunicum AB (publ) Bokslutskommuniké 2019

Pressmeddelande 18 februari 2020 Immunicum AB (publ) Bokslutskommuniké 2019 OKTOBER – DECEMBER I SAMMANDRAG Nettoomsättning för kvartalet uppgick till - KSEK (- KSEK).Kvartalets resultat uppgick...
February 18, 2020 02:00 ET | Source: Immunicum AB

Immunicum AB (publ) Year-End Report 2019

Press Release 18 February 2020 Immunicum AB (publ) Year-End Report 2019 October – December in Summary Net sales for the period amounted to KSEK - (-).Result for the quarter amounted to KSEK...
February 14, 2020 09:00 ET | Source: Taconic Biosciences

Taconic Biosciences Expands Humanized Mouse Model Production

RENSSELAER, N.Y., Feb. 14, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces its humanized immune system mice models are now...
February 12, 2020 16:05 ET | Source: Fluidigm Corporation

Fluidigm to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...